Jelly babies
A new study is reporting a method for producing human-derived gelatin, which could provide a substitute for some of the 300??000 tons of animal-based gelatin produced annually.
Gelatin is a well-known biopolymer, especially prominent in the food industry where it is used in gummy sweets and marshmallows, but also used in the pharmaceutical industry for drug capsules and in the cosmetics industry. A new study is reporting a method for producing human-derived gelatin,1 which could provide a substitute for some of the 300 000 tons of animal-based gelatin produced annually.
Gelatin is usually made from the bones and skin of cows and pigs, which may carry a risk of infectious diseases such as “Mad Cow” disease, and can lead to allergic reactions in some people. To avoid this, researchers have developed a method where human gelatin genes are inserted into a strain of yeast, that can produce gelatin with controllable features.
Gel electrophoresis and liquid chromatography coupled with tandem mass spectrometry analysis were used to confirm that the results contained the necessary gelatin proteins. Further spectroscopic tests revealed characteristics consistent with those of gelatin.
The researchers are still testing the human-yeast gelatin to see how well it compares with other gelatins in terms of its viscosity and other attributes.
1. H. Duan et al., J. Agric. Food Chem., 59(13), 7127–7134 (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
